Weekly Digest – November 2026 Weekly Digest – November 2026 13 November 2026: Imfinzi approved in the US in novel regimen with neoadjuvant Enfortumab vedotin for patients with muscle-invasive bladder cancer AstraZeneca received US FDA approval on 13 November 2026 for […]